Figure 2.
Risk of congestive heart failure among 1244 autologous BMT recipients with and without hypertension and diabetes who received high-dose anthracyclines. The presence of hypertension among recipients of high-dose anthracyclines (≥250 mg/m2) resulted in a 35-fold increased risk of CHF; the risk was nearly 27-fold for high-dose anthracycline recipients with diabetes. DM, diabetes mellitus; HD, high-dose; HTN, hypertension. Adapted from Armenian et al.5
